A prospective longitudinal study comparing a radical retropubic prostatectomy and permanent prostate brachytherapy regarding the health-related quality of life for localized prostate cancer

Japanese Journal of Clinical Oncology

Volumn 38, Issue 7, 2008, Pages 480-485

  Hashine, Katsuyoshi ^a   Kusuhara, Yoshito ^a   Miura, Noriyoshi ^a   Shirato, Akitomi ^a   Sumiyoshi, Yoshiteru ^a   Kataoka, Masaaki ^a  

^a NATIONAL HOSPITAL ORGANIZATION SHIKOKU CANCER CENTER   (Japan)

Author keywords

Localized prostate cancer; Permanent prostate brachytherapy; Quality of life; Radical retropubic prostatectomy

Indexed keywords

ADULT; AGED; ARTICLE; BRACHYTHERAPY; CLINICAL DECISION MAKING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; HEALTH SURVEY; HUMAN; INTERMETHOD COMPARISON; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MICTURITION DISORDER; OUTCOME ASSESSMENT; PROSTATE CANCER; QUALITY OF LIFE; RADICAL RETROPUBIC PROSTATECTOMY; SEXUAL DYSFUNCTION; SEXUAL FUNCTION; STOMACH FUNCTION DISORDER; SURGICAL APPROACH;

ADULT; AGED; AGED, 80 AND OVER; BRACHYTHERAPY; ERECTILE DYSFUNCTION; HEALTH STATUS; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; PROSTATE-SPECIFIC ANTIGEN; PROSTATECTOMY; PROSTATIC NEOPLASMS; QUALITY OF LIFE; RECTAL DISEASES; URINATION DISORDERS;

EID: 48849101136     PISSN: 03682811     EISSN: 14653621     Source Type: Journal    
DOI: 10.1093/jjco/hyn059     Document Type: Article

References (19)

1. Sylvester JE, Grimm PD, Blasko JC, Millar J, Orio PF, 3rd, Skoglund S, et al. 15-Year biochemical relapse free survival in clinical Stage T1-T3 prostate cancer following combined external beam radiotherapy and brachytherapy; Seattle experience. Int J Radiat Oncol Biol Phys 2007;67:57-64.
2. Kupelian PA, Potters L, Khuntia D, Ciezki JP, Reddy CA, Reuther AM, et al. Radical prostatectomy, external beam radiotherapy <72 Gy, external beam radiotherapy ≥72 Gy, permanent seed implantation, or combined seeds/external beam radiotherapy for stage T1-T2 prostate cancer. Int J Radiat Oncol Biol Phys 2004;58:25-33.
3. Litwin MS, Gore JL, Kwan L, Brandeis JM, Lee SP, Witbers HR, et al. Quality of life after surgery, external beam irradiation, or brachytherapy for early-stage prostate cancer. Cancer 2007;109:2239-47.
4. Davis JW, Kuban DA, Lynch DF, Schellhammer PF. Quality of life after treatment for localized prostate cancer: Differences based on treatment modality. J Urol 2001;166:947-52.
5. Brandeis JM, Litwin MS, Burnison CM, Reiter RE. Quality of life outcomes after brachytherapy for early stage prostate cancer. J Urol 2000;163:851-7.
6. Saito S, Nagata H, Kosugi M, Toya K, Yorozu A. Brachytherapy with permanent seed implantation. Int J Clin Oncol 2007;12:395-407.
7. Namiki S, Satoh T, Baba S, Ishiyama H, Hayakawa K, Saito S, et al. Quality of life after brachytherapy or radical prostatectomy for localized prostate cancer: A prospective longitudinal study. Urology 2006;68: 1230-6.
8. Fukuhara S, Bito S, Green J, Hsiao A, Kurokawa K. Translation, adaptation, and validation of the SF-36 Health Survey for use in Japan. J Clin Epidemiol 1998;51:1037-44.
9. Kakehi Y, Kamoto T, Ogawa O, Arai Y, Litwin MS, Suzukamo Y, et al. Development of Japanese version of the UCLA Prostate Cancer Index: A pilot validation study. Int J Clin Oncol 2002;7:306-11.
10. Yoshimura K, Arai Y, Ichioka K, Matsui Y, Ogura K, Terai A. A 3-y prospective study of health-related and disease-specific quality of life in patients with nonmetastatic prostate cancer treated with radical prostatectomy or external beam radiotherapy. Prostate Cancer Prostatic Dis 2004;7:144-51.
11. Namiki S, Saito S, Satoh M, Ishidoya S, Kawamura S, Tochigi T, et al. Quality of life after radical prostatectomy in Japanese men: 2 year longitudinal study. Jpn J Clin Oncol 2005;35:551-8.
12. Namiki S, Egawa S, Baba S, Terachi T, Usui Y, Terai A, et al. Recovery of quality of life in year after laparoscopic or retropubic radical prostatectomy: A multi-institutional longitudinal study. Urology 2005:65:517-23.
13. Litwin MS. Melmed GY, Kakazon T. Life after radical prostatectomy: A longitudinal study. J Urol 2001;166:587-92.
14. Wei JT, Dunn RL, Sandler HM, McLaughlin PW, Montie JE, Litwin MS, et al. Comprehensive comparison of health-related quality of life after contemporary therapies for localized prostate cancer. J Clin Oncol 2002;20:557-66.
15. Okaneya T, Nishizawa S, Nakayama T, Kamigaito T, Hashida I, Hosaka N. Permanent prostate brachytherapy for Japanese men: Results from initial 100 patients with prostate cancer. Int J Urol 2007;14:602-6.
16. Ohashi T, Yorozu A, Toya K, Saito S, Momma T, Nagata H, et al. Rectal morbidity following I-125 prostate brachytherapy in relation to dosimetry. Jpn J Clin Oncol 2007;37:121-6.
17. Wei J, Dunn RL, Litwin MS, Sandler HM, Sanda MG. Development and validation of the expanded prostate cancer index composite (EPIC) for comprehensive assessment of health-related quality of life in men with prostate cancer. Urology 2000;56:899-905.
18. Takegami M, Suzukamo Y, Sanda MG, Kamoto T, Namiki S, Arai Y, et al. The Japanese translation and cultural adaptation of expanded prostate cancer index composite (EPIC). Nippon Hinyokika Gakkai Zasshi 2005;96:657-69 (in Japanese).
19. Frank SJ, Pisters LL, Davis J, Lee AK, Bassett R, Kuban DA. An assessment of quality of life following radical prostatectomy, high dose external beam radiation therapy and brachytherapy iodine implantation as monotherapies for localized prostate cancer. J Urol 2007;177:2151-6.